Richard E Lowenthal insider trades

Open-market stock purchases and sales by Richard E Lowenthal, PRESIDENT AND CEO at ARS Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 8, 2022.

Recent trades

DateStockTradeValue
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • SPRY ARS Pharmaceuticals, Inc: 61 sales, last Jan 2, 2026

Get free alerts when Richard E Lowenthal files a new trade →